Nursing care
Cyclosporine: what to check before you give it
Written and reviewed by Dana Whitfield, RN, MSN · 4 min read · Updated September 2026
Short answer
Cyclosporine is a calcineurin inhibitor used to prevent organ transplant rejection, and it demands close monitoring because its therapeutic and toxic doses sit close together. Nurses draw trough levels before the next dose, watch renal function and blood pressure, check the gums, and tell patients to avoid grapefruit, which raises drug levels.
Mechanism, simply
Cyclosporine binds cyclophilin inside T lymphocytes and blocks calcineurin, an enzyme the cell needs to switch on interleukin-2 production. Without IL-2, T cells cannot proliferate, and the immune response that would otherwise attack a transplanted organ is suppressed.
This is a targeted suppression rather than a blunt one. Cyclosporine leaves most other white cell lines relatively untouched, which is why it does not cause the profound neutropenia seen with some chemotherapy agents, but it still leaves the patient vulnerable to infection and, over years, to certain cancers.
Indications you will see on the ward
Cyclosporine is a mainstay of solid organ transplantation, given after kidney, liver, heart and lung transplants to prevent rejection. It is usually combined with other agents, such as mycophenolate or a corticosteroid, as part of a multi-drug regimen rather than used alone.
Outside transplant medicine, you will also see it prescribed for severe rheumatoid arthritis unresponsive to other therapy, severe psoriasis, and some cases of nephrotic syndrome. The dosing and monitoring intensity differ between indications, so always check the specific target trough range on the chart rather than assuming a transplant protocol applies.
Assessment before administration
Check the most recent trough level against the ordered target range before giving the dose. Trough samples are drawn immediately before the next scheduled dose, typically just before the morning dose, because levels drawn at the wrong time are uninterpretable and can lead to a dangerous dose change.
Review renal function, since cyclosporine is directly nephrotoxic and a rising creatinine may mean the dose needs reducing rather than increasing. Check blood pressure, as hypertension is common and may need its own treatment, and inspect the gums for early hyperplasia at each admission. Confirm the patient has not started or stopped any interacting drug, and give the dose at a consistent time relative to meals, since food affects absorption and consistency matters more than any single rule.
Toxicity and the antidote
There is no specific reversal agent for cyclosporine toxicity. Management is supportive: hold the dose, correct fluid and electrolyte disturbances, and treat hypertension or seizures if they occur. Severe overdose may prompt discussion of haemodialysis, though cyclosporine is highly protein-bound and dialysis removes only a limited amount.
Nephrotoxicity is the toxicity you will encounter most often, presenting as a rising creatinine and falling urine output, and it can occur even within the therapeutic range in a dehydrated or volume-depleted patient. Neurotoxicity can also appear, with tremor, headache, or, rarely, seizures at high levels. Report a trough above target promptly rather than waiting for the next scheduled level.
Interactions that matter
Grapefruit and grapefruit juice inhibit the CYP3A4 enzyme that metabolises cyclosporine, and even a single glass can push levels into the toxic range. Tell every patient on this drug to avoid grapefruit in any form, permanently.
Other CYP3A4 inhibitors, including several azole antifungals and macrolide antibiotics, raise cyclosporine levels and increase toxicity risk, while enzyme inducers such as rifampin and phenytoin lower levels and risk rejection. Nephrotoxic drugs, particularly NSAIDs and aminoglycosides, compound the kidney risk when combined with cyclosporine. Live vaccines are contraindicated because of the immunosuppression, and any new prescription, including over-the-counter products, should be checked against the transplant team's list before it is started.
What the patient must be told
No grapefruit, in any form, at any time. This single instruction prevents one of the most common causes of unexpected toxicity in transplant patients and is worth repeating at every teaching opportunity.
Patients need to understand that missing doses risks organ rejection, so adherence matters even when they feel well. Teach them to report gum swelling or bleeding to their dentist and transplant team, since hyperplasia can progress and may need a medication review. Excess hair growth and tremor are also common and worth mentioning so patients are not alarmed. Sun protection is important given the raised skin cancer risk with long-term immunosuppression, and any fever, sore throat, or sign of infection should prompt an urgent call rather than a wait-and-see approach.
The next step on this is the same as on everything else here: answer questions and read the rationales. Our pharmacology practice questions are the closest set to what this page covers.
One question from the pharmacology set
A client with heart failure is started on furosemide 40 mg PO daily. Which findings should the nurse report to the provider before administering the next dose? Select all that apply.
Rationale
Furosemide is a loop diuretic, so the two things you are watching are potassium and kidney function. A potassium of 2.9 mEq/L is below the 3.5–5.0 reference range and puts the client at risk for dysrhythmia — hold and report. Muscle cramps with palpitations are the clinical face of that same hypokalemia, so they are reported together, not separately. A creatinine that doubles signals the diuresis has outrun renal perfusion. A blood pressure of 132/78 and a 1 kg loss are the expected response to the drug working, not reasons to hold it.
Answer: A, D, E
Common questions
When should a cyclosporine trough level be drawn?
Immediately before the next scheduled dose, most often just prior to the morning dose. Drawing it at any other time gives a result that cannot be compared against the target range and can lead to an inappropriate dose adjustment.
Why can't patients on cyclosporine eat grapefruit?
Grapefruit inhibits the CYP3A4 enzyme that metabolises cyclosporine, which can raise blood levels into the toxic range from a single serving. Patients are told to avoid it entirely and indefinitely, not just around dosing times.
Is cyclosporine nephrotoxic even at therapeutic levels?
Yes. Nephrotoxicity can occur within the target trough range, particularly if the patient is dehydrated or on another nephrotoxic drug. Renal function should be monitored regardless of where the trough level sits.
What oral finding is classically linked to cyclosporine?
Gingival hyperplasia, an overgrowth of the gum tissue that can make oral hygiene difficult and sometimes requires dental referral. It is a recognised long-term effect and a common NCLEX detail.
More on pharmacology
Guides on this